title: Effect of insulin and contraction on glycogen synthase phosphorylation and kinetic properties in epitrochlearis muscles from lean and obese Zucker rats.
abstract: In the present study, the effects of insulin and contraction on glycogen synthase (GS) kinetic properties and phosphorylation were investigated in epitrochlearis muscles from lean and obese Zucker rats. Total GS activity and protein expression were ~15% lower in epitrochlearis from obese rats compared with lean rats. Insulin-stimulated GS fractional activity and affinity for UDP-glucose were lower (higher K(m)) in muscles from obese rats. GS Ser(641) and Ser(645,649,653,657) phosphorylation was higher in insulin-stimulated muscles from obese rats, which agreed with lower GS activation. Contraction-mediated GS dephosphorylation of Ser(641), Ser(641+645), Ser(645,649,653,657), and Ser(7+10) was normal in muscles from obese Zucker rats, and GS fractional activity increased to similar levels in epitrochlearis muscles from lean and obese rats. GS affinity for UDP glucose was ~0.8, ~0.4, and ~0.1 mM with assay buffers containing 0, 0.17, and 12 mM glucose 6-phosphate, respectively. Contraction increased affinity for UDP-glucose (reduced K(m)) at a physiological concentration of glucose 6-phosphate (0.17 mM) to ~0.2 mM in muscles from both lean and obese rats. Interestingly, in the absence of glucose 6-phosphate in the assay buffer, contraction (and insulin) did not influence GS affinity for UDP-glucose, indicating that affinity is regulated by sensitivity for glucose 6-phosphate. In conclusion, contraction-mediated activation and dephosphorylation of GS were normal in muscles from obese Zucker rats, whereas insulin-mediated GS activation and dephosphorylation were impaired.
authors.affiliation: Department of Physical Performance, Norwegian School of Sport Sciences, P. O. Box 4014 Ullevål Stadion, N-0806 Oslo, Norway.
authors.forename: Fang Chin
authors.initials: FC
authors.lastname: Lin
authors.forename: Astrid
authors.initials: A
authors.lastname: Bolling
authors.forename: Jorid T
authors.initials: JT
authors.lastname: Stuenæs
authors.forename: Kristoffer T
authors.initials: KT
authors.lastname: Cumming
authors.forename: Ada
authors.initials: A
authors.lastname: Ingvaldsen
authors.forename: Yu-Chiang
authors.initials: YC
authors.lastname: Lai
authors.forename: John L
authors.initials: JL
authors.lastname: Ivy
authors.forename: Jørgen
authors.initials: J
authors.lastname: Jensen
mesh_terms: D000818:Animals; D005260:Female; D006006:Glycogen Synthase / Q000378:metabolism* / Q000493:pharmacokinetics; D007328:Insulin / Q000493:pharmacokinetics / Q000502:physiology*; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D009765:Obesity / Q000201:enzymology / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects / Q000502:physiology; D051381:Rats; D011924:Rats, Zucker; D013851:Thinness / Q000201:enzymology / Q000378:metabolism
chemical_list: D007328:Insulin; D006006:Glycogen Synthase